Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Migraine with and without aura

Neurology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

A first thunderclap headache, persistent new neurological deficit, atypical motor weakness, impaired consciousness, fever or meningism, papilloedema, pregnancy-associated severe headache, acute painful Horner syndrome or a substantial new pattern change requires urgent secondary-headache assessment rather than attribution to migraine aura.

Synopsis

Diagnose migraine positively from its episodic phenotype, distinguish typical aura from vascular or epileptic mimics, and recognise when a changing pattern needs secondary-headache investigation.

  • Migraine is a positive clinical diagnosis: recurrent attacks commonly last 4–72 hours and combine moderate or severe headache with nausea or sensitivity to light and sound.
  • The pain may be unilateral or bilateral, often pulsating and aggravated by routine activity, but no single descriptor is required when the overall pattern is characteristic.
  • Typical aura is fully reversible visual, sensory or speech disturbance that develops gradually over at least 5 minutes and usually lasts 5–60 minutes for each symptom.
  • Positive spreading phenomena, such as scintillation or marching paraesthesia, favour aura; abrupt maximal negative loss, persistent deficit or simultaneous symptoms raise concern for TIA or another cause.
  • Aura may precede, accompany or occur without headache, and an individual can have attacks both with and without aura across their lifetime.
  • Use a headache diary for at least 8 weeks when diagnosis or burden is uncertain, recording frequency, duration, severity, associated symptoms, medicines, triggers and menstruation.
  • Do not image a stable typical migraine solely for reassurance when examination is normal and there are no secondary features; explain the positive diagnosis and safety net instead.
  • Offer contraception and vascular-risk counselling where relevant: current UKMEC classifies combined hormonal contraception as category 4 in migraine with aura, so it should not be used while safer contraceptive options are discussed.
  • Diagnose chronic migraine when headache occurs on at least 15 days per month for more than 3 months with migraine features on at least 8 days, while also assessing medication overuse.

Key red flags

Atypical aura feature

Motor weakness, diplopia, monocular visual symptoms, reduced consciousness or impaired balance requires further assessment because it falls outside straightforward typical-aura diagnosis.

Migraine mimic

Sudden fixed deficit, first or worst abrupt pain, seizure features, fever, papilloedema or progressive personality change should move the clinician away from uncomplicated migraine.

Investigation priorities

01
Structured headache historyFirst step

Make a positive migraine diagnosis and identify a meaningful change or secondary-headache feature.

Management branches

DiagnosisBuild the recurrent attack phenotype

A person reports episodic headache with or without transient neurological symptoms.

  1. Establish duration, frequency, onset speed, pain behaviour, nausea, sensory sensitivity, disability and complete recovery, then compare every feature with previous attacks.
  2. For neurological symptoms record whether phenomena were positive or negative, gradual or abrupt, sequential or simultaneous, and fully reversible within the expected duration.
  3. Screen for systemic, vascular, pressure, pregnancy and examination red flags before assigning migraine with or without aura.
  4. Explain the positive diagnosis, begin a diary when useful and agree separate plans for acute treatment, prevention threshold and urgent reassessment.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CG150 headaches in over 12sDiagnostic features, aura, diaries, imaging and safety guidance.
  • British Association for the Study of Headache guidelinesUK specialist diagnostic and management framework for migraine.
  • International Classification of Headache Disorders migraineInternational diagnostic criteria for episodic, chronic and aura subtypes.
  • CoSRH UKMEC 2025 contraceptive eligibility criteriaCurrent UK contraceptive safety classification, including category 4 for combined hormonal contraception in migraine with aura.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom